NCT00094380View on ClinicalTrials.gov

Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Lupus Erythematosus, SystemicLupus Nephritis
Interventions
DRUG

CTLA4-IgG4m (RG2077)

DRUG

Cyclophosphamide

Trial Locations (2)

10032

Columbia University Medical Center, New York

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

Immune Tolerance Network (ITN)

NETWORK

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00094380 - Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077) | Biotech Hunter | Biotech Hunter